Meanwhile, it was also found that the guanine replaced the 559th cytosine on one patient and two carriers from the third family, which made the 116th leucine replaced by valine.
PatientID: II-4
KindredID: 3
Case: M, Age Unknown (deceased), Chinese
DiseaseAssertion: CNS Hemangioblastoma
FamilyInfo: The transition mutation was found and confirmed in 1 patient (II-3) and 2 carriers (III-7, IV-2). 5 members, including II-4, had hemangioblastomas of the CNS, but had all passed away before genetic testing. Could be assumed and deduced the genetics due to pedigree showing future linear relations of this mutation.
CasePresentingHPOs: HP:0010797 (hemangioblastoma)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
PreviouslyPublished: N/A
SupplementalData: N/A
Variant: p.L116V (c.346C>G) [assumed]
LegacyVariant: p.L116V (c.559C>G) [assumed]
CaseProblemVariantFreeText: N/A
ClinVarID: N/A
CAID: CA351753642 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.346C%3EG
gnomAD: N/A
VariantEvidence: No genetic testing was done prior to death, however family history and presentation leads to this assumption
MutationType: missense_variant;transversion
CivicName: L116V (c.346C>G)
MultipleGeneVariants: N/A